Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease (ADHERE)
24. maj 2017 opdateret af: Michael Vaezi, Vanderbilt University Medical Center
ADHERE Study: Application of Dx-pH Catheter for Extra-esophageal Reflux Evaluation
The purpose of this study is to establish the clinical application of a new device that records pH changes in the hypopharynx.
The investigators also aim to compare the consistency of distal esophageal pH with hypopharyngeal pH using both the "short" and the "long" catheters in patients.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Gastroesophageal reflux disease (GERD) has been linked to many disorders and can be diagnosed through a variety of modalities utilizing 24 hour ambulatory pH monitoring which can register the duration, pattern and symptom correlation of distal esophageal acid exposure.
This can be accomplished via a catheter probe connected from outside the body and placed through a nostril, advanced past the hypopharynx and down into the distal esophagus.
Or, a small pH detector temporarily implanted in the distal esophagus during endoscopy can record reflux events.
However, despite available technologies, there has long been a deficiency in detecting extra-esophageal reflux in the upper esophagus/ hypopharynx.
This is of interest for gastroenterologists, otolaryngologists, and pulmonologists in the evaluation of extra-esophageal reflux as a potential culprit for asthma, chronic cough, laryngitis, globus, and non-cardiac chest pain.
Until now, there has not been a device sensitive enough for accurately detecting extra-esophageal reflux (EERD) and clinicians have relied upon subjective response to empiric treatment with acid reducing medications to determine whether acid reflux was at the root of the symptoms.
There are currently no well designed published studies with this device to assess its role in this group of difficult to treat patients.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
47
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232
- Vanderbilt Medical Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 65 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Male and female volunteers aged 18 to 65 years old.
- Control group: No known history of GERD or EERD or prior PPI use.
- GERD group: Patients with known history of GERD based on prior response to either histamine inhibitors (H2 blockers) or proton pump inhibitors (PPIs) and/or endoscopic esophagitis identified at endoscopy.
- EERD group: Patients with chronic cough, asthma and laryngeal findings felt to be GERD related.
Exclusion Criteria:
- Use of H2 blockers or PPIs within one week prior to and during the study for the GERD and EERD patients. No prior PPI use is allowed for the control population.
- Use of antacids (Rolaids, Tums, Pepto-Bismol, etc.) within one day prior to or during the study.
- Esophageal motility abnormalities (achalasia, esophageal spasm, severe dysphagia)
- Expected non-compliance.
- Positive history of ongoing alcohol or tobacco use and inability to refrain from using either during study duration (24 hours).
- Recent nasal surgery or nasal obstruction.
- Significant medical conditions that, in the investigator's judgment, would compromise the subject's health and safety (mental disability, psychiatric impairment, inability to read or comprehend the consent form)
- Pregnancy
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: 1
Healthy volunteers with no history of GERD or EERD or Proton Pump Inhibitor (PPI) use
|
24 hour ph monitoring
procedure to measure pH at the Lower esophageal sphincter (LES) and Upper esophageal sphincter (UES)
|
|
Eksperimentel: 2
subject is known to have GERD based on symptoms and previous positive response to PPI
|
24 hour ph monitoring
procedure to measure pH at the Lower esophageal sphincter (LES) and Upper esophageal sphincter (UES)
|
|
Eksperimentel: 3
subject is known to have EERD based on symptoms and previous positive response to PPI
|
24 hour ph monitoring
procedure to measure pH at the Lower esophageal sphincter (LES) and Upper esophageal sphincter (UES)
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Decrease in pH From Baseline to <4
Tidsramme: 24 hours
|
The three study groups underwent dual pH measurements of the oropharyngeal as well as esophageal acid exposure employing the regular length probe for the oropharynx and the custom-designed long probe for the distal esophagus.
The reason for the custom-designed esophageal measurement was to ensure that events noted in the oropharynx originated distally and were of gastric source.
Measurements for the two locations were time synchronized to ensure accuracy.
Calculations were based on length of time spent in upright and supine positions, and a combination of the two positions.
|
24 hours
|
|
Decrease in pH From Baseline to <5
Tidsramme: 24 hours
|
The three study groups underwent dual pH measurements of the oropharyngeal as well as esophageal acid exposure employing the regular length probe for the oropharynx and the custom-designed long probe for the distal esophagus.
The reason for the custom-designed esophageal measurement was to ensure that events noted in the oropharynx originated distally and were of gastric source.
Measurements for the two locations were time synchronized to ensure accuracy.
Calculations were based on length of time spent in upright and supine positions, and a combination of the two positions.
Reflux event was calculated for a drop in pH from baseline to either <4, or <5, or <6 and each event had to last more than 5 seconds and could not be during the meals.
|
24 hours
|
|
Decrease in pH From Baseline to <6
Tidsramme: 24 hours
|
The three study groups underwent dual pH measurements of the oropharyngeal as well as esophageal acid exposure employing the regular length probe for the oropharynx and the custom-designed long probe for the distal esophagus.
The reason for the custom-designed esophageal measurement was to ensure that events noted in the oropharynx originated distally and were of gastric source.
Measurements for the two locations were time synchronized to ensure accuracy.
Calculations were based on length of time spent in upright and supine positions, and a combination of the two positions.
Reflux event was calculated for a drop in pH from baseline to either <4, or <5, or <6 and each event had to last more than 5 seconds and could not be during the meals.
|
24 hours
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Reflux Events
Tidsramme: 24 hours
|
Reflux event was calculated for a drop in pH from baseline to <6 and each event had to last more than 5 seconds and could not be during the meals.
|
24 hours
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Michael F Vaezi, MD, PhD, MS, Vanderbilt University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. oktober 2006
Primær færdiggørelse (Faktiske)
1. september 2012
Studieafslutning (Faktiske)
1. juli 2013
Datoer for studieregistrering
Først indsendt
13. oktober 2006
Først indsendt, der opfyldte QC-kriterier
13. oktober 2006
Først opslået (Skøn)
16. oktober 2006
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
27. juni 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. maj 2017
Sidst verificeret
1. maj 2017
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 060860
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .